Skip to main content

Kenneth L. Schaecher, MD, FACP, CPC

Authored Items
A Payer’s Perspective on CDK4/6 Inhibitors
Kenneth L. Schaecher, MD, FACP, CPC
Abemaciclib (Verzenio™), a Novel CDK4/6 Inhibitor, in the Treatment of Hormone Receptor–Positive, HER2-Negative Advanced Breast Cancer in CDK4/6 Inhibitors
Impact of the Affordable Care Act on Cancer Care: A Payer’s Perspective
Kenneth L. Schaecher, MD, FACP, CPC
Conquering the Cancer Care Continuum - Series Three: Fourth Issue in Supplements
Last modified: April 3, 2018